Liver X receptors as therapeutic targets for managing cholesterol: implications for inflammatory conditions

Bibliography

• Kannel WB, Castelli WP, Gordon T: Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann. Intern. Med. 90(1), 85–91 (1979)
   Google Scholar
• Vuoristo M, Miettinen TA: Absorption, metabolism, and serum concentrations of cholesterol in vegetarians: effects of cholesterol feeding. Am. J. Clin. Nutr. 59(6), 1325–1331 (1994)
   Google Scholar
• Brunner D, Weisbort J, Meshulam N et al.: Relation of serum total cholesterol and high-density lipoprotein cholesterol percentage to the incidence of definite coronary events: twenty-year follow-up of the Donolo-Tel Aviv Prospective Coronary Artery Disease Study. Am. J. Cardiol. 59(15), 1271–1276 (1987)
   Google Scholar
• Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR: High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am. J. Med. 62(5), 707–714 (1977)
   Google Scholar
• Grundy SM: Atherogenic dyslipidemia: lipoprotein abnormalities and implications for therapy. Am. J. Cardiol. 75(6), 45B–52B (1995)
   Google Scholar
• Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D: Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet 2(8513), 933–936 (1986)
   Google Scholar
• Hausenloy DJ, Yellon DM: Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels. Heart 94(6), 706–714 (2008).
   Google Scholar
• Detailed review discussing the antiatherosclerotic properties of HDL-C and the pharmacological strategies for raising HDL-C levels.
   Google Scholar
• Attie AD, Kastelein JP, Hayden MR: Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis. J. Lipid Res. 42(11), 1717–1726 (2001)
   Google Scholar
• Navab M, Hama SY, Anantharamaiah GM et al.: Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3. J. Lipid Res. 41(9), 1495–1508 (2000)
   Google Scholar
• Navab M, Hama SY, Cooke CJ et al.: Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. J. Lipid Res. 41(9), 1481–1494 (2000)
   Google Scholar
• Brown MS, Goldstein JL: Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 52, 223–261 (1983)
   Google Scholar
• Glass CK, Witztum JL: Atherosclerosis. The road ahead. Cell 104(4), 503–516 (2001).
   Google Scholar
• Detailed review discussing the molecular mechanisms involved in atherosclerosis and the potential new therapeutic targets for prevention and treatment.
   Google Scholar
• Casserly I, Topol E: Convergence of atherosclerosis and Alzheimer’s disease: inflammation, cholesterol, and misfolded proteins. Lancet 363(9415), 1139–1146 (2004)
   Google Scholar
• Hotamisligil GS: Inflammation and metabolic disorders. Nature 444(7121), 860–867 (2006)
   Google Scholar
• Chadban SJ, Atkins RC: Glomerulonephritis. Lancet 365(9473), 1797–1806 (2005)
   Google Scholar
• Galli SJ, Tsai M, Piliponsky AM: The development of allergic inflammation. Nature 454(7203), 445–454 (2008)
   Google Scholar
• Janowski BA, Grogan MJ, Jones SA et al.: Structural requirements of ligands for the oxysterol liver X receptors LXRβ and LXRα. Proc. Natl. Acad. Sci. USA 96(1), 266–271 (1999)
   Google Scholar
• Kalaany NY, Mangelsdorf DJ: LXRS and FXR: the yin and yang of cholesterol and fat metabolism. Annu. Rev. Physiol. 68, 159–191 (2006)
   Google Scholar
• Repa JJ, Mangelsdorf DJ: The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu. Rev. Cell Dev. Biol. 16, 459–481 (2000)
   Google Scholar
• Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, Mangelsdorf DJ: LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev. 9(9), 1033–1045 (1995)
   Google Scholar
• Wagner BL, Valledor AF, Shao G et al.: Promoter-specific roles for liver X receptor/ corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression. Mol. Cell Biol. 23(16), 5780–5789 (2003)
   Google Scholar
• Molteni V, Li X, Nabakka J et al.: N-acylthiadiazolines, a new class of liver X receptor agonists with selectivity for LXRβ. J. Med. Chem. 50(17), 4255–4259 (2007)
   Google Scholar
• Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, Mangelsdorf DJ: Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126(4), 789–799 (2006)
   Google Scholar
• Lehmann JM, Kliewer SA, Moore LB et al.: Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem. 272(6), 3137–3140 (1997)
   Google Scholar
• Peet DJ, Turley SD, Ma W et al.: Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXRα. Cell 93(5), 693–704 (1998)
   Google Scholar
• Zhang Y, Repa JJ, Gauthier K, Mangelsdorf DJ: Regulation of lipoprotein lipase by the oxysterol receptors, LXRα and LXRβ. J. Biol. Chem. 276(46), 43018–43024 (2001)
   Google Scholar
• Hu X, Li S, Wu J, Xia C, Lala DS: Liver X receptors interact with corepressors to regulate gene expression. Mol. Endocrinol. 17(6), 1019–1026(2003)
   Google Scholar
• Endo A: The discovery and development of HMG-CoA reductase inhibitors.J. Lipid Res. 33(11), 1569–1582 (1992)
   Google Scholar
• Sudhop T, Lutjohann D, Kodal A et al.: Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Circulation 106(15), 1943–1948 (2002)
   Google Scholar
• Agellon LB, Drover VA, Cheema SK, Gbaguidi GF, Walsh A: Dietary cholesterol fails to stimulate the human cholesterol 7α-hydroxylase gene (CYP7A1) in transgenic mice. J. Biol. Chem. 277(23), 20131–20134 (2002)
   Google Scholar
• Costet P, Luo Y, Wang N, Tall AR: Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/ retinoid X receptor. J. Biol. Chem. 275(36), 28240–28245 (2000)
   Google Scholar
• Kennedy MA, Venkateswaran A, Tarr PT et al.: Characterization of the human ABCG1 gene: liver X receptor activates an internal promoter that produces a novel transcript encoding an alternative form of the protein. J. Biol. Chem. 276(42), 39438–39447 (2001)
   Google Scholar
• Repa JJ, Berge KE, Pomajzl C, Richardson JA, Hobbs H, Mangelsdorf DJ: Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors α and β. J. Biol. Chem. 277(21), 18793–18800 (2002)
   Google Scholar
• Repa JJ, Turley SD, Lobaccaro JA et al.: Regulation of absorption and ABC1- mediated efflux of cholesterol by RXR heterodimers. Science. 289(5484), 1524–1529 (2000)
   Google Scholar
• Schwartz K, Lawn RM, Wade DP: ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR. Biochem. Biophys. Res. Commun. 274(3), 794–802 (2000)
   Google Scholar
• Singaraja RR, Bocher V, James ER et al.: Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1. J. Biol. Chem. 276(36), 33969–33979 (2001)
   Google Scholar
• Venkateswaran A, Repa JJ, Lobaccaro JM, Bronson A, Mangelsdorf DJ, Edwards PA: Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols. J. Biol. Chem. 275(19), 14700–14707 (2000)
   Google Scholar
• Yu L, Gupta S, Xu F et al.: Expression of ABCG5 and ABCG8 is required for regulation of biliary cholesterol secretion. J. Biol. Chem. 280(10), 8742–8747 (2005)
   Google Scholar
• Repa JJ, Liang G, Ou J et al.: Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ. Genes Dev. 14(22), 2819–2830 (2000)
   Google Scholar
• Cao G, Liang Y, Broderick CL et al.: Antidiabetic action of a liver X receptor agonist mediated by inhibition of hepatic gluconeogenesis. J. Biol. Chem. 278(2), 1131–1136 (2003)
   Google Scholar
• Grefhorst A, van Dijk TH, Hammer A et al.: Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ ob mice. Am. J. Physiol. Endocrinol. Metab. 289(5), E829–E838 (2005)
   Google Scholar
• Laffitte BA, Chao LC, Li J et al.: Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc. Natl Acad. Sci. USA 100(9), 5419–5424 (2003).
   Google Scholar
• In vivo and in vitro studies demonstrating that liver X recpeptor (LXR) modulates genes involved in glucose metabolism and activation of LXR improves glucose tolerance in a diet-induced obesity and insulin-resistance model.
   Google Scholar
• Grempler R, Gunther S, Steffensen KR et al.: Evidence for an indirect transcriptional regulation of glucose-6- phosphatase gene expression by liver X receptors. Biochem. Biophys. Res. Commun. 338(2), 981–986 (2005)
   Google Scholar
• Herzog B, Hallberg M, Seth A, Woods A, White R, Parker MG: The nuclear receptor cofactor, receptor-interacting protein 140, is required for the regulation of hepatic lipid and glucose metabolism by liver X receptor. Mol. Endocrinol. 21(11), 2687–2697 (2007)
   Google Scholar
• Stulnig TM, Oppermann U, Steffensen KR, Schuster GU, Gustafsson JA: Liver X receptors downregulate 11β-hydroxysteroid dehydrogenase type 1 expression and activity. Diabetes 51(8), 2426–2433 (2002)
   Google Scholar
• Lee MH, Lu K, Patel SB: Genetic basis of sitosterolemia. Curr. Opin. Lipidol. 12(2), 141–149 (2001)
   Google Scholar
• Kruit JK, Groen AK, van Berkel TJ, Kuipers F: Emerging roles of the intestine in control of cholesterol metabolism. World J. Gastroenterol. 12(40), 6429–6439 (2006)
   Google Scholar
• Kruit JK, Plosch T, Havinga R et al.: Increased fecal neutral sterol loss upon liver X receptor activation is independent of biliary sterol secretion in mice. Gastroenterology 128(1), 147–156 (2005)
   Google Scholar
• Mulligan JD, Flowers MT, Tebon A et al.: ABCA1 is essential for efficient basolateral cholesterol efflux during the absorption of dietary cholesterol in chickens. J. Biol. Chem. 278(15), 13356–13366 (2003)
   Google Scholar
• Murthy S, Born E, Mathur SN, Field FJ: LXR/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells. J. Lipid Res. 43(7), 1054–1064 (2002)
   Google Scholar
• Brunham LR, Kruit JK, Pape TD, Parks JS, Kuipers F, Hayden MR: Tissue-specific induction of intestinal ABCA1 expression with a liver X receptor agonist raises plasma HDL cholesterol levels. Circ. Res. 99(7), 672–674 (2006)
   Google Scholar
• Laffitte BA, Repa JJ, Joseph SB et al.: LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc. Natl Acad. Sci. USA 98(2), 507–512 (2001)
   Google Scholar
• Joseph SB, McKilligin E, Pei L et al.: Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc. Natl Acad. Sci. USA 99(11), 7604–7609 (2002)
   Google Scholar
• Levin N, Bischoff ED, Daige CL et al.: Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists. Arterioscler. Thromb. Vasc. Biol. 25(1), 135–142 (2005)
   Google Scholar
• Terasaka N, Hiroshima A, Koieyama T et al.: T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice. FEBS Lett. 536(1–3), 6–11 (2003)
   Google Scholar
• Kennedy MA, Barrera GC, Nakamura K et al.: ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab. 1(2), 121–131 (2005)
   Google Scholar
• Sabol SL, Brewer HB Jr, Santamarina-Fojo S: The human ABCG1 gene: identification of LXR response elements that modulate expression in macrophages and liver. J. Lipid Res. 46(10), 2151–2167 (2005)
   Google Scholar
• Venkateswaran A, Laffitte BA, Joseph SB et al.: Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR α. Proc. Natl Acad. Sci. USA 97(22), 12097–12102 (2000)
   Google Scholar
• Naik SU, Wang X, Da Silva JS et al.: Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo. Circulation 113(1), 90–97 (2006).
   Google Scholar
• Elegant in vivo radiotracer experiment demonstrating that activation of LXR promotes reverse cholesterol transport from macrophages to feces for elimination.
   Google Scholar
• Hansson GK, Robertson AK, Soderberg-Naucler C: Inflammation and atherosclerosis. Annu. Rev. Pathol. 1, 297–329 (2006)
   Google Scholar
• Castrillo A, Joseph SB, Vaidya SA et al.: Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol. Cell. 12(4), 805–816 (2003)
   Google Scholar
• Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P: Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9(2), 213–219 (2003)
   Google Scholar
• Joseph SB, Bradley MN, Castrillo A et al.: LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 119(2), 299–309 (2004)
   Google Scholar
• Blaschke F, Leppanen O, Takata Y et al.: Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in ballooninjured rat carotid arteries. Circ. Res. 95(12), E110–E123 (2004)
   Google Scholar
• Imayama I, Ichiki T, Patton D et al.: Liver X receptor activator downregulates angiotensin II type 1 receptor expression through dephosphorylation of Sp1. Hypertension 51(6), 1631–1636 (2008)
   Google Scholar
• Cummins CL, Volle DH, Zhang Y et al.: Liver X receptors regulate adrenal cholesterol balance. J. Clin. Invest. 116(7), 1902–1912 (2006)
   Google Scholar
• Nilsson M, Stulnig TM, Lin CY et al.: Liver X receptors regulate adrenal steroidogenesis and hypothalamic– pituitary–adrenal feedback. Mol. Endocrinol. 21(1), 126–137 (2007)
   Google Scholar
• Steffensen KR, Neo SY, Stulnig TM et al.: Genome-wide expression profiling; a panel of mouse tissues discloses novel biological functions of liver X receptors in adrenals. J. Mol. Endocrinol. 33(3), 609–622 (2004)
   Google Scholar
• Robertson KM, Schuster GU, Steffensen KR et al.: The liver X receptor-β is essential for maintaining cholesterol homeostasis in the testis. Endocrinology 146(6), 2519–2530 (2005)
   Google Scholar
• Steffensen KR, Robertson K, Gustafsson JA, Andersen CY: Reduced fertility and inability of oocytes to resume meiosis in mice deficient of the Lxr genes. Mol. Cell. Endocrinol. 256(1–2), 9–16 (2006)
   Google Scholar
• Volle DH, Mouzat K, Duggavathi R et al.: Multiple roles of the nuclear receptors for oxysterols liver X receptor to maintain male fertility. Mol. Endocrinol. 21(5), 1014–1027 (2007)
   Google Scholar
• Gong H, Guo P, Zhai Y et al.: Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor. Mol. Endocrinol. 21(8), 1781–1790 (2007)
   Google Scholar
• Kolsch H, Lutjohann D, Ludwig M et al.: Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer’s disease. Mol. Psychiatry 7(8), 899–902 (2002)
   Google Scholar
• Lutjohann D, von Bergmann K: 24S-hydroxycholesterol: a marker of brain cholesterol metabolism. Pharmacopsychiatry 36 (Suppl. 2), S102–S106 (2003)
   Google Scholar
• Liang Y, Lin S, Beyer TP et al.: A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes. J. Neurochem. 88(3), 623–634 (2004)
   Google Scholar
• Sun Y, Yao J, Kim TW, Tall AR: Expression of liver X receptor target genes decreases cellular amyloid β peptide secretion. J. Biol. Chem. 278(30), 27688–27694 (2003)
   Google Scholar
• Whitney KD, Watson MA, Collins JL et al.: Regulation of cholesterol homeostasis by the liver X receptors in the central nervous system. Mol. Endocrinol. 16(6), 1378–1385 (2002)
   Google Scholar
• Burns MP, Vardanian L, Pajoohesh-Ganji A et al.: The effects of ABCA1 on cholesterol efflux and Aβ levels in vitro and in vivo. J. Neurochem. 98(3), 792–800 (2006)
   Google Scholar
• Koldamova R, Staufenbiel M, Lefterov I: Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice. J. Biol. Chem. 280(52), 43224–43235 (2005)
   Google Scholar
• Zelcer N, Khanlou N, Clare R et al.: Attenuation of neuroinflammation and Alzheimer’s disease pathology by liver X receptors. Proc. Natl Acad. Sci. USA 104(25), 10601–10606 (2007).
   Google Scholar
• In vivo study showing that loss of LXRs in APP/PS1 AD-transgenic mice resulted in increased amyloid deposition owing to the defects in cholesterol homeostasis and inflammatory responses in the brain. It further identified LXRs as therapeutic targets in Alzheimer’s disease.
   Google Scholar
• Muscat GE, Wagner BL, Hou J et al.: Regulation of cholesterol homeostasis and lipid metabolism in skeletal muscle by liver X receptors. J. Biol. Chem. 277(43), 40722–40728 (2002)
   Google Scholar
• Delvecchio CJ, Bilan P, Nair P, Capone JP: LXR-induced reverse cholesterol transport in human airway smooth muscle is mediated exclusively by ABCA1. Am. J. Physiol. Lung Cell. Mol. Physiol. 295(5), L949–L957 (2008)
   Google Scholar
• Delvecchio CJ, Bilan P, Radford K et al.: Liver X receptor stimulates cholesterol efflux and inhibits expression of proinflammatory mediators in human airway smooth muscle cells. Mol. Endocrinol. 21(6), 1324–1334 (2007).
   Google Scholar
• 2Birrell MA, Catley MC, Hardaker E et al.: Novel role for the liver X nuclear receptor in the suppression of lung inflammatory responses. J. Biol. Chem. 282(44), 31882–31890 (2007)
   Google Scholar
• Birrell MA, De Alba J, Catley MC et al.: Liver X receptor agonists increase airway reactivity in a model of asthma via increasing airway smooth muscle growth. J. Immunol. 181(6), 4265–4271 (2008)
   Google Scholar
• Morello F, de Boer RA, Steffensen KR et al.: Liver X receptors α and β regulate renin expression in vivo. J. Clin. Invest. 115(7), 1913–1922 (2005)
   Google Scholar
• Proctor G, Jiang T, Iwahashi M, Wang Z, Li J, Levi M: Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with Type 1 diabetes. Diabetes 55(9), 2502–2509 (2006)
   Google Scholar
• Baigent C, Keech A, Kearney PM et al.: Efficacy and safety of cholesterol-lowering treatment: prospective meta-ana lysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366(9493), 1267–1278 (2005)
   Google Scholar
• Groot PH, Pearce NJ, Yates JW et al.: Synthetic LXR agonists increase LDL in CETP species. J. Lipid Res. 46(10), 2182–2191 (2005)
   Google Scholar
• Luo Y, Tall AR: Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element. J. Clin. Invest. 105(4), 513–520 (2000)
   Google Scholar
• Quinet EM, Savio DA, Halpern AR, Chen L, Miller CP, Nambi P: Geneselective modulation by a synthetic oxysterol ligand of the liver X receptor. J. Lipid Res. 45(10), 1929–1942 (2004)
   Google Scholar
• Kratzer A, Buchebner M, Pfeifer T et al.: Synthetic LXR agonist attenuates plaque formation in apoE-deficient mice without inducing liver steatosis and hypertriglyceridemia. J. Lipid Res. DOI:10.1194/jlr.M800376-JLR200 (2008) (Epub ahead of print)
   Google Scholar
• Hu B, Quinet E, Unwalla R et al.: Carboxylic acid based quinolines as liver X receptor modulators that have LXRβ receptor binding selectivity. Bioorg. Med. Chem. Lett. 18(1), 54–59 (2008)
   Google Scholar
• Lund EG, Peterson LB, Adams AD et al.: Different roles of liver X receptor α and β in lipid metabolism: effects of an α-selective and a dual agonist in mice deficient in each subtype. Biochem. Pharmacol. 71(4), 453–463 (2006)
   Google Scholar
• Quinet EM, Savio DA, Halpern AR et al.: Liver X receptor (LXR)-β regulation in LXRα-deficient mice: implications for therapeutic targeting. Mol. Pharmacol. 70(4), 1340–1349 (2006)
   Google Scholar
• Bradley MN, Hong C, Chen M et al.: Ligand activation of LXR β reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR α and apoE. J. Clin. Invest. 117(8), 2337–2346 (2007).
   Google Scholar
• In vivo mechanistic study supporting drug development strategies targeting LXR β for the treatment of atherosclerosis.
   Google Scholar
• Beyea MM, Heslop CL, Sawyez CG et al.: Selective up-regulation of LXR-regulated genes ABCA1, ABCG1, and APOE in macrophages through increased endogenous synthesis of 24(S),25-epoxycholesterol. J. Biol. Chem. 282(8), 5207–5216 (2007).
   Google Scholar